港通医疗
(301515)
| 流通市值：12.94亿 | | | 总市值：20.33亿 |
| 流通股本：6367.38万 | | | 总股本：1.00亿 |
| 报告期 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 24,286,732.74 | 754,058,316.42 | 492,343,391.1 | 436,943,414.18 |
| 营业收入 | 24,286,732.74 | 754,058,316.42 | 492,343,391.1 | 436,943,414.18 |
| 二、营业总成本 | 33,730,745.31 | 701,180,141.37 | 465,870,677.19 | 409,447,472.98 |
| 营业成本 | 15,507,795.01 | 604,228,113.76 | 393,756,754.41 | 356,362,849.74 |
| 税金及附加 | 882,604.66 | 5,201,822.9 | 3,012,045.35 | 1,897,578.9 |
| 销售费用 | 7,380,721.28 | 39,985,388.19 | 36,511,363.41 | 27,631,241.24 |
| 管理费用 | 6,194,321.4 | 31,796,379.32 | 21,863,945.08 | 15,734,219.05 |
| 研发费用 | 4,280,463.49 | 24,245,229.96 | 15,071,489.98 | 11,143,197.52 |
| 财务费用 | -515,160.53 | -4,276,792.76 | -4,344,921.04 | -3,321,613.47 |
| 其中:利息费用 | 1,605,605.99 | 6,314,008.83 | 4,400,271.22 | 3,099,061.57 |
| 其中:利息收入 | 2,162,019.44 | 11,244,971.62 | 9,214,293.41 | 6,805,441.59 |
| 加:公允价值变动收益 | - | 957,316.41 | - | - |
| 资产处置收益 | - | 75,411.84 | 31,789.3 | 6,971.37 |
| 资产减值损失(新) | -120,228.6 | -643,638.58 | 180,456.75 | -228,104.33 |
| 信用减值损失(新) | 10,872,919.37 | -47,778,144.26 | -7,876,300.95 | -12,013,629.52 |
| 其他收益 | 230,194.1 | 7,843,434.68 | 2,784,840.93 | 1,396,289.75 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | 1,538,872.3 | 13,332,555.14 | 21,593,499.94 | 16,657,468.47 |
| 加:营业外收入 | 18,237.59 | 2,066,516.09 | 720,644.53 | 375,464.49 |
| 减:营业外支出 | 52,437.67 | 298,270.94 | 116,388.09 | 98,755.41 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | 1,504,672.22 | 15,100,800.29 | 22,197,756.38 | 16,934,177.55 |
| 减:所得税费用 | -74,280.4 | 678,933.85 | 2,151,451.69 | 1,520,489.48 |
| 六、净利润 | 1,578,952.62 | 14,421,866.44 | 20,046,304.69 | 15,413,688.07 |
| 持续经营净利润 | 1,578,952.62 | 14,421,866.44 | 20,046,304.69 | 15,413,688.07 |
| 归属于母公司股东的净利润 | 1,578,952.62 | 14,421,866.44 | 20,046,304.69 | 15,413,688.07 |
| (一)基本每股收益 | 0.02 | 0.15 | 0.2 | 0.15 |
| (二)稀释每股收益 | 0.02 | 0.15 | 0.2 | 0.15 |
| 八、其他综合收益 | - | -127,348.69 | -127,650.4 | -175,027.07 |
| 归属于母公司股东的其他综合收益 | - | -127,348.69 | -127,650.4 | -175,027.07 |
| 九、综合收益总额 | 1,578,952.62 | 14,294,517.75 | 19,918,654.29 | 15,238,661 |
| 归属于母公司股东的综合收益总额 | 1,578,952.62 | 14,294,517.75 | 19,918,654.29 | 15,238,661 |
| 公告日期 | 2025-04-21 | 2025-04-21 | 2024-10-24 | 2024-08-28 |
| 审计意见(境内) | | 标准无保留意见 | | |